insights_auto
Why is ORX down 3,58%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,84 SEK
arrow_downward
-3,58%(-0,031) 1D
13 қар., 15:13:16 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
291,96 млн
Avg. vol.
739,90 м.
Volume
839,93 м.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
291,96 млн
Avg. vol.
739,90 м.
Volume
839,93 м.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Foreign Policy Journal
·
11 минут бұрын
OKX And NYSE Parent ICE Build Tokenized Securities Venue That Runs On Uniswap V4 Pools, Targeting November 23 Debut With 70+ Assets Including
www.marketscreener.com
·
20 минут бұрын
VVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
Quartz
·
21 минут бұрын
Dow futures rise 323 points as Nvidia rebounds, PPI comes in light
Bloomberg.com
·
4 сағат бұрын
Goldman Sees S&P 500 Rising 14% on Cheap Hyperscaler Valuations
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com